Phase 3 Alzheimer's Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You must be between 55 and 90 years old at the time of your first screening visit.
- You must have been diagnosed with Alzheimer's disease based on the most recent 2024 Alzheimer's Association guidelines.
- You must have had a brain scan (MRI or CT) within the past 5 years, taken after your dementia symptoms began, to rule out other brain conditions such as stroke or tumors.
- You must have been experiencing psychotic symptoms (such as hallucinations or delusions) for at least 2 months before your screening visit — you may or may not also have symptoms of agitation.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- You may not be eligible if your psychotic symptoms are caused by a condition other than Alzheimer's disease, such as schizophrenia, schizoaffective disorder, delusional disorder, or a mood disorder with psychotic features.
- You may not be eligible if you have had a major depressive episode with psychotic features in the past 12 months, or if you have a history of bipolar disorder, schizophrenia, or schizoaffective disorder.
- You may not be eligible if certain safety concerns are identified, including abnormal results on specific laboratory tests (confirm with trial site for details).
- There are additional eligibility requirements not listed here that the trial team will review with you (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change From Baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.